Michael W. Freeman
Stock Analyst at Raymond James
(2.42)
# 2,978
Out of 4,504 analysts
44
Total ratings
36.7%
Success rate
3.1%
Average return
Main Sectors:
Stocks Rated by Michael W. Freeman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: APTX Apotex Health Corp. | Initiated Coverage: Buy | $36.00 | $38.00 | -5.26% | 1 | Jul 6, 2026 | |
| TSX: AIDX Healwell AI Inc. | Maintained: Buy | $3.00 → $2.50 | $0.76 | +228.95% | 5 | Mar 25, 2026 | |
| TSX: HLS HLS Therapeutics Inc. | Maintained: Buy | $6.00 → $7.00 | $4.31 | +62.41% | 2 | Nov 18, 2025 | |
| TSX: WELL WELL Health Technologies Corp. | Maintained: Buy | n/a | $4.41 | - | 5 | Nov 6, 2025 | |
| TSX: PRN Profound Medical Corp. | Maintained: Buy | $15.59 | $10.05 | +55.13% | 4 | Oct 8, 2025 | |
| TSX: MDP Medexus Pharmaceuticals Inc. | Maintained: Buy | $8.00 | $5.19 | +54.14% | 9 | Aug 14, 2025 | |
| TSX: VHI Vitalhub Corp. | Maintained: Buy | $14.50 → $15.00 | $7.31 | +105.20% | 6 | Aug 12, 2025 | |
| TSX: BHC Bausch Health Companies Inc. | Maintained: Hold | $11.34 | $6.77 | +67.49% | 7 | Aug 5, 2025 | |
| NGEN NervGen Pharma | Maintained: Buy | $3.17 → $4.23 | $1.88 | n/a | 3 | Jun 11, 2025 | |
| TSX: GUD Knight Therapeutics Inc. | Maintained: Buy | $8.00 | $9.80 | n/a | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1.50 | $0.33 | n/a | 1 | Nov 18, 2024 |
Apotex Health Corp.
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $36.00
Current: $38.00
Upside: -5.26%
Healwell AI Inc.
Mar 25, 2026
Maintained: Buy
Price Target: $3.00 → $2.50
Current: $0.76
Upside: +228.95%
HLS Therapeutics Inc.
Nov 18, 2025
Maintained: Buy
Price Target: $6.00 → $7.00
Current: $4.31
Upside: +62.41%
WELL Health Technologies Corp.
Nov 6, 2025
Maintained: Buy
Price Target: n/a
Current: $4.41
Upside: -
Profound Medical Corp.
Oct 8, 2025
Maintained: Buy
Price Target: $15.59
Current: $10.05
Upside: +55.13%
Medexus Pharmaceuticals Inc.
Aug 14, 2025
Maintained: Buy
Price Target: $8.00
Current: $5.19
Upside: +54.14%
Vitalhub Corp.
Aug 12, 2025
Maintained: Buy
Price Target: $14.50 → $15.00
Current: $7.31
Upside: +105.20%
Bausch Health Companies Inc.
Aug 5, 2025
Maintained: Hold
Price Target: $11.34
Current: $6.77
Upside: +67.49%
NervGen Pharma
Jun 11, 2025
Maintained: Buy
Price Target: $3.17 → $4.23
Current: $1.88
Upside: n/a
Knight Therapeutics Inc.
Mar 12, 2025
Maintained: Buy
Price Target: $8.00
Current: $9.80
Upside: n/a
Nov 18, 2024
Upgraded: Buy
Price Target: $1.50
Current: $0.33
Upside: n/a